Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    The struggle is real: The first half of 2023 was an uphill climb

    The struggle is real: The first half of 2023 was an uphill climb

    FromThe BioWorld Insider Podcast

    Start listeningView podcast show

    The struggle is real: The first half of 2023 was an uphill climb

    FromThe BioWorld Insider Podcast

    ratings:
    Length:
    26 minutes
    Released:
    Aug 16, 2023
    Format:
    Podcast episode

    Description

    Guests Karen Carey, BioWorld’s managing editor, and Mike Ward, Clarivate’s global head of Life Sciences and Healthcare Thought Leadership, discuss the deals, financing and M&A landscape for the first half of 2023 and how U.K. biopharmas are faring post Brexit.
    Released:
    Aug 16, 2023
    Format:
    Podcast episode

    Titles in the series (38)

    Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective work is changing how we all live. Join us each week for a new conversation. Hosted on Acast. See acast.com/privacy for more information.